Brochure | March 11, 2026

Peptide & Oligonucleotide: CDMO Overview

Source: Asymchem
Peptide-GettyImages-175437411

Advancing complex TIDES programs requires partners who can unite cutting‑edge science with dependable large‑scale execution. This overview highlights a comprehensive approach to peptide and oligonucleotide development, covering both established and emerging synthetic strategies that help teams navigate increasing molecular complexity with confidence. Readers will find a clear breakdown of solid‑phase, liquid‑phase, and flow‑enabled synthesis options — along with specialized capabilities such as enzymatic ligation, tag‑assisted methods, and robust blockmer‑based strategies.

The flyer also introduces advanced digital modeling tools, including aggregation and retention‑time prediction supported by deep learning and molecular‑dynamics simulations, designed to accelerate process understanding before scale‑up. A full suite of downstream and purification solutions — ranging from prep‑HPLC and MCSGP to TFF, lyophilization, and spray drying — demonstrates how integrated operations can shorten timelines while maintaining product quality.

Finally, readers gain insight into large‑scale manufacturing capacity, raw‑material reliability, and AI‑guided process development, making this a strong resource for teams seeking efficient, scalable, and future‑ready TIDES production. Access the full flyer to explore capabilities in detail.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma